Cargando…
Expression of GP88 (progranulin) in serum of prostate cancer patients is associated with Gleason scores and overall survival
BACKGROUND: GP88/Progranulin is a well-recognized cell growth promoter in different cancers, and elevated serum GP88 levels have been described as negative prognostic factor in breast cancer. However, serum levels in prostate cancer (PCa) patients have not yet been studied. MATERIAL AND METHODS: We...
Autores principales: | Greither, Thomas, Fischer, Kersten, Theil, Gerit, Marcou, Marios, Holzhausen, Hans-Juergen, Weigelt, Katrin, Serrero, Ginette, Hicks, David, Yue, Binbin, Fornara, Paolo, Wullich, Bernd, Taubert, Helge, Wach, Sven, Lieb, Verena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6178934/ https://www.ncbi.nlm.nih.gov/pubmed/30323673 http://dx.doi.org/10.2147/CMAR.S172069 |
Ejemplares similares
-
Expression of GP88 (Progranulin) Protein Is an Independent Prognostic Factor in Prostate Cancer Patients
por: Abdulrahman, Amer, et al.
Publicado: (2019) -
Combined miR-486 and GP88 (Progranulin) Serum Levels Are Suggested as Supportive Biomarkers for Therapy Decision in Elderly Prostate Cancer Patients
por: Fichte, Alexander, et al.
Publicado: (2022) -
Signaling Pathway of GP88 (Progranulin) in Breast Cancer Cells: Upregulation and Phosphorylation of c-myc by GP88/Progranulin in Her2-Overexpressing Breast Cancer Cells
por: Kim, Wes E., et al.
Publicado: (2016) -
Serum levels of miR-320 family members are associated with clinical parameters and diagnosis in prostate cancer patients
por: Lieb, Verena, et al.
Publicado: (2017) -
Combination of GP88 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Is an Independent Prognostic Factor for Bladder Cancer Patients
por: Eckstein, Markus, et al.
Publicado: (2021)